期刊文献+

同型半胱氨酸在扩张型心肌病心力衰竭左室重构和心肌损伤中的临床意义 被引量:10

Clinical significance of homocysteine in dilated cardiomyopathy heart failure with left ventricular remodeling and myocardial damage
下载PDF
导出
摘要 目的探讨同型半胱氨酸(HCY)在扩张型心肌病心力衰竭左室重构和心肌损伤中的临床意义。方法选取2008年3月至2012年6月扩张型心肌病(DCM)心衰患者89例,按照HCY水平分为HCY正常组43例和HCY升高组46例,观察血清HCY水平与左室射血分数、左室舒张末期容积、左室短轴缩短率和左室后壁厚度以及心肌酶学、血清肌钙蛋白的关系。结果与HCY正常组比较HCY升高组的LVEDV显著升高(P<0.01),LVEF、LVFS和LVPW显著降低(P<0.05),HCY升高组的CK-MB、AST和LDH水平显著升高(P<0.05),cTnT和cTnI水平显著升高(P<0.01),以上两组间的差异均有统计学意义。结论血清HCY可作为DCM心力衰竭左室重构和心肌损伤严重程度的有效评价指标。 Objective To study the clinical significance of homocysteine (HCY) in dilated cardiomyopathy heart failure with left ventricular remodeling and myocardial damage. Methods Eighty-nine patients with dilated car- diomyopathy (DCM) heart failure from March 2008 to June 2012 were divided into normal HCY group (n=43) and increased HCY group (n=46) according to serum HCY levels. The relationship between serum homocysteine levels and left ventricular ejection fraction (LVEF), left ventricular end-diastolic volume (LVEDV), left ventricular fraction- al shortening rate (LVFS) and left ventricular posterior wall thickness (LVPW), serum cardiac enzymes, and serum troponin were observed. Results LVEDV was significantly higher in normal HCY group than increased HCY group (P〈0.01). LVEF, LVFS and LVPW were significantly lower in normal HCY group than increased HCY group (P〈0.05). CK-MB, AST and LDH were significantly higher in normal HCY group than increased HCY group (P〈0.05), as well as cTnT and cTnI (P〈0.01). Conclusion Serum HCY can be used as the effective evaluation of severity in patients of DCM heart failure with left ventricular remodeling and myocardial damage.
出处 《海南医学》 CAS 2013年第4期478-480,共3页 Hainan Medical Journal
关键词 扩张型心肌病 同型半胱氨酸 超声心动图描记 心肌酶学 肌钙蛋白 Dilated cardiomyopathy Homocysteine Echocardiography tracings Cardiac enzymes Troponin
  • 相关文献

参考文献10

  • 1Alam MA, Hasain SA, Narang R, et al. Association of polymor- phism in the thermolabile 5,10-methylene tetrahydrofolate reduc- tase gene and hyperhomocysteinemia with coronary artery disease [J]. Mol Cell Biochem, 2008, 310(1-2): 111-117.
  • 2Lenzen H, Tsikas D, Boger RH. Asymmetric dimethylarginine (AD- MA) and the risk for coronary heart disease: the multicenter CAR- DIAC study [J]. Eur J Clin Pharmacol, 2006, 62(13): 45-49.
  • 3虞敏 苏本恩.心肌损伤的血清生化指标[A].见:杨英珍主编.病毒性心脏病[C].上海:上海科学技术出版}十,2001.189.
  • 4Greenberg B. Treatment of heart failure: state of the art and prospec- tives [J]. J Cardiovasc Pharmacol, 2001, 38(12): 59-63.
  • 5吴亚玲.病理生理学[M].北京:北京大学医学出版社,2003:209-212.
  • 6Missov E, Mair J. A novel biochemical approach to congestive heart failure: cardiac troponin T [J]. Am Heart J, 1999, 138(11): 95-99.
  • 7何军,赵敏,戚新,王宇,李路,王鹤,张磊.充血性心力衰竭时甲状腺激素和肌钙蛋白Ⅰ的变化[J].中华急诊医学杂志,2004,13(7):465-467. 被引量:12
  • 8Hansch A, Rzanrty R, Heyne JP, et al. Noninvasive measurements of cardiac high-energy phosphate metabolites in dilated cardiomyopathy by using spectroscopic chemical shift imaging [J]. Eur Radiol, 2005, 15(2): 319-323.
  • 9戴闺柱.心力衰竭生物学治疗的新认识[J].中华心血管病杂志,2000,28(4):314-316. 被引量:146
  • 10Amesen E, Refsum H, Bonaa KH, et al. Serum total homocysteine and coronary heart disease [J]. Int J Epidemiol, 1995, 24(4): 704-709.

二级参考文献8

  • 1Carter JN, Eastman CJ, Corcoran JM, et al. Effect of severe chronic illness on thyroid function. Lancet, 1974,2:971.
  • 2Bodor GS, Pot Porter S, Landt Y, et al. Devetopmen. t of monoclong antibodies for an assay of cardiac troponin-I andpreliminary results jn suspected cases of myocardial infarction. Clin Chem, 1992,38:2203-2214.
  • 3La-Vecchia L, Mezzena G, Ometto R, et al. Detectable serum troponin-T in patients with heart failure of nonmyocardial ischemic origin. Am J Cardiol, 1997,80: 88-90.
  • 4Missov E, Calzolari C, Pau B. High circulating levels of cardiac troponin-I in human congestive heart failure. J AM Coil Cardiol, 1996,27:338.
  • 5Missov E,Bodor GS, Davila-Roman VG, et al. Cardiac troponinI:Marker with high specificity for cardiac injury. Circulation, 1993,88:101-106.
  • 6Kimura G,Tkanda T, Knwabara A, et al. Participation of the pitutarythyroid axis in the cardiovasc patients with congestive heart failure. Am J Med, 1997,28:75.
  • 7张新庆,程爱国,庞琳,韩向午.C肽、皮质醇和甲状腺激素在判断脑外伤预后中的作用[J].急诊医学,2000,9(5):314-316. 被引量:2
  • 8陈谱,何韶衡,王鲁华.充血性心力衰竭患儿甲状腺激素水平与心衰原发病关系的探讨[J].中华急诊医学杂志,2003,12(3):191-192. 被引量:3

共引文献157

同被引文献66

  • 1张源源,吴军,王鲁妮.脑钠肽的生物学特性及在心脏损害中的应用[J].广东医学,2007,28(2):323-325. 被引量:17
  • 2柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2143
  • 3Potluri S,Ventura HO,Mulumudi M,et al. Cardiac troponin levels in heart failure[J].Cardiol Rev,2004,12(1):21-25.
  • 4Francis GS.Pathophysiology of chronic heart failure[J].Am J Med, 2001,110(Suppl 7A):S 37- S46.
  • 5Smith OR, Gidron Y, Kupper N, et al. Vital exhaustion in chronic heart failure: symptom profiles and clinical outcome[ J]. J Psychosom Res, 2009,66( 3 ) : 195-201.
  • 6Larsson DA, Meurling C J, Holmqvist F, et al. The diagnostic and prog- nostic value of brain natriuretic peptides in adults with a systemic mor- phologically right ventricle or Fontan-type circulation[ J]. Int J Cardi- ol,2007,114 ( 3 ) : 345-351.
  • 7Heinrich J, Shuhe H, Schonfeld R. Association of variables of aoagnla- tion,fibrinolysis and acute phase with atherosclemsis in coronary and peripheral arteries and those arteries supplying the brain [ J ]. Thromb Haemost,2005,73 (3) :374-379.
  • 8Lenzen H, Tsikas D, Boger RH. Asymmetric dimethylarginine (AD- MA) and the risk for coronary heart disease:the multicenter CARDIAC study [ J ]. Eur J Clin Pharmacol,2009,62 ( 13 ) :45 -49.
  • 9Joseph J, Joseph L, Shekhawat NS, et al. Hyperhomocysteinemia leads to pathological ventricular hypertrophy in normotensive rats[ J]. Am J Physiol Heart Circ Physiol,2009,285 (3) :679-686.
  • 10Herrmann M, Kindermann I, Muller S, et al. Relationship of plasma homocystein with the severity of chronic heart failure [ J ]. Clin Chen, 2010,51 (8) :1512-1515.

引证文献10

二级引证文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部